用GAD65抗体治疗自身免疫叶的管理:四个病例报告
József Janszky1,2, Beáta Bóné1, Kázmér Karádi3
1Department of Neurology, Medical School University of Pecs, Pécs, Hungary.
Neurologia i neurochirurgia polska
|August 2, 2024
概括
在耐药叶 (TLE) 中早期检测谷氨酸脱酶 (GAD) 65抗体可以改善治疗结果. 及时的免疫调节疗法或手术可以导致自由和认知改善.
科学领域:
- 神经免疫学 神经免疫学
- 发病学 (Epileptology) 是一个专业的学科.
- 自免疫性疾病 自免疫性疾病
背景情况:
- 人们越来越多地认识到自身免疫性,其中谷氨酸脱酶 (GAD) 65抗体向细胞内抗原.
- GAD65抗体阳性与药物耐药的叶 (TLE) 有关.
研究的目的:
- 探索GAD65抗体的TLE患者的临床特征和治疗策略.
- 评估免疫调节剂和手术干预措施在该患者队列中的有效性.
主要方法:
- 四名TLE患者的病例系列具有GAD65抗体阳性,其中包括两名1型糖尿病患者.
- 由于药物耐药性,进行了手术前评估.
- 分析电临床数据,治疗反应和结果.
主要成果:
- 一名患者在前叶切除后实现了无发作.
- 两名患者在免疫调节剂治疗后出现了有限的改善.
- 一名患者在静脉注射免疫球蛋白 (IVIg) 治疗中经历了显著的和认知改善,特别是在疾病持续时间较短的情况下.
结论:
- 早期检测GAD65抗体与使用免疫调节疗法更好地控制和改善认知状态有关.
- 虽然手术可以诱导发作自由,但它会带来认知能力下降的风险.
- 及时诊断和向治疗对于管理GAD65抗体相关的TLE至关重要.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
305
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
305
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators
363
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
363


